Live News EARNINGS H impact Jul 23, 2026, 05:22 AM UTC

Roche Q2/H1 2026 Earnings

Sales CHF15.64B (est CHF15.53B) - Q2 Ocrevus Sales CHF1.78B (est CHF1.79B) - Q2 Diagnostics Sales CHF3.48B (est CHF3.47B) - H1 Sales CHF30.36B (est CHF30.32B) - H1 Core EPS CHF10.85 (est CHF 10.05)

SquawkNews Newsroom 1 updates Updated Jul 23, 2026, 05:32 AM UTC

Story updates

05:32:01 AM UTC

SquawkNews

Roche Q2/H1 2026 Earnings

Sales CHF15.64B (est CHF15.53B) - Q2 Ocrevus Sales CHF1.78B (est CHF1.79B) - Q2 Diagnostics Sales CHF3.48B (est CHF3.47B) - H1 Sales CHF30.36B (est CHF30.32B) - H1 Core EPS CHF10.85 (est CHF 10.05)